A 5-year-old child is admitted to the pediatric unit with a diagnosis of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infection. The child has completed 48 hours of intravenous vancomycin therapy. Which nursing intervention is most appropriate at this time?
The nurse is caring for a pediatric patient with CA-MRSA infection who has been receiving antibiotic therapy for 2 days.
1Discontinue contact precautions since the child has received 48 hours of antibiotic therapy
2Prepare the child for discharge planning as the infection should be resolving
3Switch to oral antibiotics immediately to reduce the risk of vancomycin-related complications
4Continue current antibiotic therapy and monitor for clinical improvement and adverse effects✓ 정답
해설
Continuing vancomycin therapy with close monitoring is essential for CA-MRSA treatment success and patient safety. Discontinuing precautions, discharge planning, or switching to oral antibiotics prematurely can lead to treatment failure or resistance.
Core Nursing ExplanationKey Concept Analysis: This question tests the principles of managing a Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) infection, focusing on the appropriate nursing interventions during the initial phase of intravenous (IV) antibiotic therapy. The core theme is understanding that effective treatment requires a full course of the correct antibiotic, and that clinical improvement and safety monitoring are ongoing nursing responsibilities, not assumptions made after a short period.
Answer Rationale: Key Point! The correct answer is to Continue current antibiotic therapy and monitor for clinical improvement and adverse effects. For a serious infection like CA-MRSA, 48 hours of IV vancomycin is just the beginning of treatment. The standard course is typically 7-14 days or longer, depending on severity. The nurse's role is to ensure the prescribed therapy is administered completely, while vigilantly assessing for two critical things: 1) Clinical Improvement (e.g., decreased redness, swelling, fever) and 2) Adverse Effects of vancomycin, such as nephrotoxicity (monitor serum creatinine, BUN), ototoxicity (report hearing changes, tinnitus), and Red Man Syndrome (flushing, rash, hypotension during infusion, managed by slowing the infusion rate).
Distractor Analysis:
Watch out for confusion! Option ① is incorrect because Contact Precautions are maintained for the duration of the illness while the infection is active and draining, not based solely on hours of antibiotic therapy. Precautions are discontinued only when the infection has resolved or based on specific culture results and institutional policy.
Option ② is premature. Discharge planning for a pediatric patient on IV antibiotics may eventually involve Outpatient Parenteral Antibiotic Therapy (OPAT), but this decision is based on clear clinical improvement, stability, and a care plan, not an arbitrary 48-hour mark. Assuming resolution is unsafe.
Option ③ is incorrect and dangerous. Vancomycin has very poor oral absorption and is only effective IV for systemic infections. Switching to oral antibiotics is a medical decision based on culture sensitivities (e.g., to clindamycin or trimethoprim-sulfamethoxazole) and clinical response, not done "immediately" to avoid complications. Premature switching can lead to treatment failure.
Related Concepts: This integrates knowledge of infection control (Standard and Transmission-Based Precautions), pharmacology (vancomycin administration and monitoring), and pediatric nursing (assessing a child's response to treatment and managing IV therapy).Nursing Clinical Practice GuideClinical Scenario: You are the nurse on a pediatric unit. Your patient, a 5-year-old named Leo, has a large, painful, red abscess on his forearm diagnosed as CA-MRSA. He is on IV vancomycin every 8 hours. After 2 days, the redness is slightly less, but the area is still warm and tender. His mother asks, "He's been on the medicine for two days, can we go home soon?"
Nursing Intervention Strategy:
Assessment: Perform a focused assessment: Measure the abscess dimensions, note drainage characteristics (color, amount, odor), assess pain level using a pediatric scale, and monitor vital signs (especially temperature). Review latest lab values (WBC, serum creatinine).
Implementation & Monitoring:
Medication Administration: Administer vancomycin IV over at least 60 minutes (for a child) to prevent Red Man Syndrome. Monitor closely during the infusion.
Infection Control: Maintain strict Contact Precautions. Wear gown and gloves upon room entry. Ensure dedicated equipment (e.g., stethoscope) is in the room. Educate the family on proper hand hygiene and precaution measures.
Wound Care: Perform wound care as ordered (e.g., packing, dressing changes) using sterile technique.
Patient/Family Education: Explain the importance of completing the full course of antibiotics. Teach signs of improvement and adverse effects to report. Discuss that discharge may involve continuing IV antibiotics at home with nurse visits, but only when he is much better.
Patient Safety and Precautions: Never rush vancomycin infusion. Ensure trough levels are drawn correctly (just before the next dose) to monitor therapeutic levels and avoid toxicity. For a draining wound, the environment is considered contaminated; perform meticulous hand hygiene before and after care.
Nursing Procedure & Medication FlowVancomycin IV Administration & Monitoring:
Step
Key Action
Rationale & Precaution
1. Preparation
Verify order, calculate dose based on weight (mg/kg). Dilute in sufficient volume (e.g., NS).
Pediatric doses are weight-based. Proper dilution prevents phlebitis.
2. Administration
Infuse via an IV pump over at least 60 minutes.
Slow infusion minimizes risk of Red Man Syndrome (histamine release).
3. Monitoring
Observe for flushing, rash, itching, hypotension during infusion. Assess IV site for phlebitis.
Early recognition allows intervention (stop infusion, notify provider, may administer antihistamine).
4. Lab Monitoring
Monitor serum vancomycin trough levels (goal typically 10-20 mcg/mL for serious infections). Monitor serum creatinine and BUN.
Ensures therapeutic level and detects early nephrotoxicity. Trough is drawn 30 minutes before next dose.
A Word from Your Senior Nurse
"In pediatrics, parents are understandably anxious and want a quick fix. Our job is to be the calm, knowledgeable guide. Explaining that 'antibiotics are like a full course of medicine—we don't stop just because you start feeling a bit better' is a great analogy. With MRSA, consistency is everything. Your vigilant monitoring of that IV site, the child's response, and lab values is what protects that little one from a relapse or a new complication. Remember, nursing is about seeing the whole picture: the bug, the drug, and the child in the bed."
CA-MRSA — Community-Associated Methicillin-Resistant Staphylococcus aureus. A strain of Staph bacteria resistant to common antibiotics (like methicillin) that is acquired outside healthcare settings, often causing skin/soft tissue infections.
Contact Precautions — A type of transmission-based precaution used for pathogens spread by direct or indirect contact. Requires use of gown and gloves upon room entry to prevent transmission.
Vancomycin — A glycopeptide antibiotic used to treat serious infections caused by Gram-positive bacteria, including MRSA. Key monitoring includes trough levels, renal function, and watching for Red Man Syndrome.
Red Man Syndrome — An infusion-related reaction to vancomycin characterized by flushing, erythema, pruritus, and sometimes hypotension, caused by histamine release. Managed by slowing the infusion rate.
Therapeutic Drug Monitoring — The practice of measuring specific drug concentrations in the blood at designated times to maintain a constant, therapeutic level and minimize toxicity. Crucial for drugs like vancomycin.